Bhutan vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Bhutan
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Bhutan rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bhutan
- Sri Lanka
How they compare
Bhutan currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 6 times across 17 shared years of data; in 2005 it was Sri Lanka ahead.
Bhutan ranks 1st and Sri Lanka ranks 1st of 180 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Bhutan | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 88.0% | 82.4% | Sri Lanka |
| 2010s | 48.5% | 85.6% | 37.1% | Sri Lanka |
| 2020s | 94.0% | 81.5% | 12.5% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bhutan or Sri Lanka?
- Bhutan, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bhutan and Sri Lanka?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Sri Lanka?
- 17 years are reported by both, from 2005 to 2024.
- How do Bhutan and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Bhutan ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.